ResMed launches Obstructive Sleep Apnea Symposium initiative
The symposium series, aligned with India’s Digital Health Mission, extends ResMed’s initiative focussed on increasing awareness of sleep disorders among healthcare professionals and promoting digital connectivity for real-time access to remote monitoring and out-of-hospital care
ResMed, a global leader in digital health and cloud-connected medical devices, announced the launch of its Obstructive Sleep Apnea (OSA) Symposium initiative, a knowledge series for healthcare professionals across Indian metros. Developed in continuance with ResMed’s sleep awareness initiative ‘Awaken Your Best,’ the series kickstarted with symposiums in key Indian cities – Delhi, Kolkata, and Hyderabad to further the importance of recognising sleep apnea as a key disorder impacting the well-being of Indians. With participation from over 250 leading sleep specialists as of now, the series also spotlights OSA and associated breathing disorders.
The symposium series, aligned with India’s Digital Health Mission, extends ResMed’s initiative focused on increasing awareness of sleep disorders among healthcare professionals and promoting digital connectivity for real-time access to remote monitoring and out-of-hospital care. With the next leg in Mumbai, Chennai and Bengaluru, the initiative enables attendees to understand and gain hands-on experience with various therapies and innovative technologies.
As part of the knowledge series, ResMed is showcasing AirView, the remote patient data monitoring software and Onesleeptest (OST), a revolutionary at-home sleep test kit, facilitating pulmonologists and sleep specialists to access real-time sleep data for diagnostics and sleep care management. These advanced cloud-connected solutions by ResMed redefine and ease the process for caregivers to effectively help patients stay comfortable and receive the full benefits of the therapy.
The symposiums witnessed participation from industry-leading pulmonologists and sleep specialists, including Dr Manvir Bhatia (Senior Neurologist and Sleep Specialist and the Director of Neurology Sleep Centre, New Delhi), Dr Sanjay Manchanda, Dr Vivek Nangia, Dr GC Khilnani, Dr Indranil Halder, Dr Arup Haldar, Dr Dipankar Dutta and Dr Sourav Das, among others. The sleep series focused on adherence to Continuous Positive Airway Pressure (CPAP) therapy, troubleshooting patient-related issues in post-PAP prescription and the consequences of untreated sleep disorders.
Commenting on the knowledge series, Dr Sibasish Dey, Head – Medical Affairs, South Asia, ResMed, said, “At ResMed, we pioneer innovative solutions that support the professionals and caregivers who help people stay healthy. The Obstructive Sleep Apnea Symposium series is one of our key initiatives to increase awareness about sleep disorders and highlight the requirement for cloud-connected care among healthcare professionals in India. Looking ahead, ResMed remains focused on delivering lifesaving therapy solutions, training healthcare professionals, and driving accelerated adoption of digital health in sleep apnea.”
Reiterating the need for awareness, Seema Arora, Business Head – Consumer & Digital, South Asia, ResMed, said, “In India, over 28 million people suffer from moderate to severe sleep apnea, making it one of the most underdiagnosed sleep disorders. However, the majority of them stay undetected or undiagnosed due to the lack of awareness. With its recently launched ‘Awaken Your Best’ initiative, ResMed is dedicatedly building recognition for sleep health as an important pillar of overall well-being with the patient and doctor community. The OSA Symposium series aims to advance the conversations about sleep disorders, new diagnostic technology and advanced CPAP solutions such as AirView among key industry stakeholders and healthcare practitioners.”
The symposiums also include a telemonitoring demonstration for sleep specialists and practitioners showcasing how remote monitoring and sleep care treatments are typically the most efficient way to manage patients and their disorders.